Bryce, A. H., Fizazi, K., Roubaud, G., Tagawa, S. T., Bernard-Tessier, A., Teyssonneau, D., Helissey, C., Dorff, T. B., Rathkopf, D., Adra, N., O'Donnell, J. F., Baeck, J., Ames, T. D., Price, M. R., Scher, H. I. (2025). Preliminary phase 2 results of PT-112 monotherapy in late-line metastatic castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.5071